{
  "name": "OOTWOracle Report Archive",
  "description": "Daily psychedelic intelligence oracle reports \u2014 falsifiable AI predictions on FDA regulatory decisions, clinical trials, biotech markets, legislation, and culture.",
  "publisher": "OOTWOracle",
  "url": "https://www.ootworacle.com",
  "feed": "https://www.ootworacle.com/feed.xml",
  "llms": "https://www.ootworacle.com/llms.txt",
  "updated": "2026-05-25",
  "total_reports": 30,
  "articles": [
    {
      "url": "https://www.ootworacle.com/report/2026-05-25",
      "title": "The Two Clocks",
      "date": "2026-05-25",
      "description": "The Two Clocks\n\nTwo distinct rhythms are governing the psychedelic ecosystem right now, and today's signals make their divergence impossible to ignore. The first is the FDA clock: the MDMA-assisted th\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-24",
      "title": "The Procedural Wall",
      "date": "2026-05-24",
      "description": "The Procedural Wall\n\nToday's swarm processed 297 signals across the psychedelic therapeutics landscape, and the clearest picture that emerges is one of structural patience being tested by human urgenc\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-23",
      "title": "The Convergence Problem",
      "date": "2026-05-23",
      "description": "The Convergence Problem\n\nToday's signal cluster arrives with unusual density. Multiple psilocybin randomized controlled trials appear in simultaneous publication \u2014 findings pointing toward efficacy in\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-22",
      "title": "The Veteran Inflection",
      "date": "2026-05-22",
      "description": "The Veteran Inflection\n\nToday's signal cluster converges on a single fault line running through the ibogaine story. A new scoping review on QT prolongation and arrhythmia risk \u2014 processed by FDA's Div\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-21",
      "title": "The Gray Market Rises",
      "date": "2026-05-21",
      "description": "The Gray Market Rises\n\nTwo ibogaine cardiac safety papers landed in the literature within the same 24-hour window this week, giving FDA reviewers precisely the evidentiary foothold they have been wait\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-20",
      "title": "The Plasticity Threshold",
      "date": "2026-05-20",
      "description": "The Plasticity Threshold\n\nA cluster of randomized controlled trials published this week has sharpened the evidentiary landscape in ways that will matter for years. Studies targeting psilocybin for maj\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-19",
      "title": "The Investable Silence",
      "date": "2026-05-19",
      "description": "The Investable Silence\n\nTwo signals crystallized today at the intersection of molecular science and market skepticism. A psilocybin-assisted RCT targeting cocaine use disorder published results showin\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-18",
      "title": "The Protocol Before the Path",
      "date": "2026-05-18",
      "description": "The Protocol Before the Path\n\nTwo cardiac safety papers on ibogaine landed in the literature today within the same news cycle as a measurable surge in veteran advocacy signal \u2014 a collision that the FD\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-17",
      "title": "Friction Before Form",
      "date": "2026-05-17",
      "description": "Friction Before Form\n\nToday's signal cluster arrives weighted with cardiac data and congressional shadow. Two ibogaine safety papers \u2014 documenting QT prolongation and arrhythmia risk in treatment cont\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-16",
      "title": "The Bifurcation Deepens",
      "date": "2026-05-16",
      "description": "The Bifurcation Deepens\n\n---\n\nFour distinct data streams converged in the past 48 hours, each arriving with enough specificity to demand individual attention. Stanford's ibogaine team published update\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-15",
      "title": "The Neuroplasticity Wager",
      "date": "2026-05-15",
      "description": "The Neuroplasticity Wager\n\nFour ibogaine cardiac safety papers published within a single reporting window have created what regulators call \"documentation density\" \u2014 the point at which accumulating ev\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-14",
      "title": "The Safety Dividend",
      "date": "2026-05-14",
      "description": "The Safety Dividend\n\nThe data cluster forming around ibogaine this week is dense and directional. Three peer-reviewed publications addressing cardiac risk \u2014 QT prolongation and ventricular arrhythmia \u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-13",
      "title": "When the Risk Becomes the Road",
      "date": "2026-05-13",
      "description": "When the Risk Becomes the Road\n\nThe dominant signal today is cardiac \u2014 not as alarm, but as clarification. A cluster of ibogaine safety papers, processed across 466 signals in today's swarm, is conver\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-12",
      "title": "The Misread Cure",
      "date": "2026-05-12",
      "description": "The Misread Cure\n\nTwo signals collided in today's data stream with the force of a fault line. A randomized controlled trial testing psilocybin for cocaine use disorder \u2014 single-site, modestly powered \u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-11",
      "title": "Underground Rising",
      "date": "2026-05-11",
      "description": "Underground Rising\n\nToday's signal load arrives weighted toward safety and constraint. Seven distinct ibogaine cardiac studies entered the literature simultaneously \u2014 a clustering event that rarely ha\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-10",
      "title": "The Cardiac Gate",
      "date": "2026-05-10",
      "description": "The Cardiac Gate\n\nToday's signal cluster is dense with ibogaine. A publication grouping on QT prolongation and ventricular arrhythmia risk \u2014 framed explicitly around \"unrecognized risk\" in opioid-adja\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-09",
      "title": "The Molecular Reckoning",
      "date": "2026-05-09",
      "description": "The Molecular Reckoning\n\nTwo cardiac safety studies landed in the published literature this week with a timing that cannot be attributed to coincidence alone \u2014 a QT-prolongation analysis and an arrhyt\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-08",
      "title": "There are veterans tonight who cannot wait for 2028",
      "date": "2026-05-08",
      "description": "The Forking Current\n\nThree simultaneous publications on ibogaine cardiac risk \u2014 each documenting QT interval prolongation as a serious and measurable hazard \u2014 have reached FDA adverse event surveillan\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-07",
      "title": "The Fragmented Threshold",
      "date": "2026-05-07",
      "description": "The Fragmented Threshold\n\nToday's signal cluster converges on a single clinical fact that is reshaping the regulatory landscape in real time: ibogaine's cardiac liability is no longer a theoretical co\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-06",
      "title": "The Inflection Arrives",
      "date": "2026-05-06",
      "description": "# OOTWOracle Daily Report \u2014 2026-05-06\n\nThe Inflection Arrives\n\nFor years the psychedelic renaissance operated at the edge of institutional legitimacy \u2014 powerful enough to generate clinical data, not \u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-05",
      "title": "The Evidentiary Tide",
      "date": "2026-05-05",
      "description": "The Evidentiary Tide\n\nA cluster of peer-reviewed publications landed in near-simultaneity today, each targeting the same fault line in the ibogaine pathway: cardiac safety. A QT prolongation analysis,\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-04",
      "title": "The Legislation Gap",
      "date": "2026-05-04",
      "description": "The Legislation Gap\n\nToday's swarm processed 370 signals against a landscape defined by two hard structural facts: the Trump psychedelic executive order and the Controlled Substances Act are now in di\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-03",
      "title": "The Safety Floor",
      "date": "2026-05-03",
      "description": "The Safety Floor\n\nThree independent papers on ibogaine's cardiac risks arrived in the literature within a single reporting window \u2014 each documenting QT prolongation profiles serious enough to demand c\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-02",
      "title": "The Stalled Clock",
      "date": "2026-05-02",
      "description": "The Stalled Clock\n\nToday's data stream carries a compound message: stillness at the surface, accumulation beneath. All four tracked psychedelic equities closed lower \u2014 MMED leading the retreat at -1.9\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-05-01",
      "title": "The Analog Turn",
      "date": "2026-05-01",
      "description": "The Analog Turn\n\nThe most consequential signal arriving on May 1st, 2026 is not a single paper \u2014 it is a consolidation. Multiple independent safety analyses of ibogaine's cardiac profile landed in the\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-04-30",
      "title": "Holding Pattern \u2014 Breaking Ground",
      "date": "2026-04-30",
      "description": "Holding Pattern \u2014 Breaking Ground\n\nThe regulatory machinery governing psychedelic medicine moved visibly this week, even where it appeared still. The DEA's institutional posture toward psilocybin and \u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-04-29",
      "title": "The Cardiac Wall",
      "date": "2026-04-29",
      "description": "# OOTWOracle Daily Report \u2014 2026-04-29\n\nThe Cardiac Wall\n\nToday's signal cluster converges on a single physiological fact that is reshaping every regulatory calculation in the psychedelic ecosystem. M\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-04-28",
      "title": "The Bifurcation",
      "date": "2026-04-28",
      "description": "The data arriving today does not announce itself with fanfare. It accumulates. Compass Pathways (CMPS) closed down 5.1% as institutional holders processed the latest cardiac scoping literature on ibog\u2026"
    },
    {
      "url": "https://www.ootworacle.com/report/2026-04-27",
      "title": "The Ibogaine Cardiac Reckoning",
      "date": "2026-04-27",
      "description": "# OOTWOracle Daily Report \u2014 2026-04-27\n\n**OOTWORACLE DAILY BRIEF \u2014 27 April 2026**\n\n**The Ibogaine Cardiac Reckoning**\n\nThree independent papers on ibogaine's cardiac liability landed in the same 48-h\u2026"
    }
  ]
}